For: | Matsumoto S, Tsuji K, Shirahama S. Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study. World J Gastroenterol 2008; 14(25): 4059-4064 [PMID: 18609691 DOI: 10.3748/wjg.14.4059] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i25/4059.htm |
Number | Citing Articles |
1 |
M. Yu. Zvyaglova, O. V. Knyazev, A. I. Parfenov. Pharmacological and clinical feature of rebamipide: new therapeutic targets. Terapevticheskii arkhiv 2020; 92(2): 104 doi: 10.26442/00403660.2020.02.000569
|
2 |
YuShuang Xu, LiNa Xiong, YaNan Li, Xin Jiang, ZhiFan Xiong. Diagnostic methods and drug therapies in patients with ischemic colitis. International Journal of Colorectal Disease 2021; 36(1): 47 doi: 10.1007/s00384-020-03739-z
|
3 |
Chiara Olivero, Federico Carbone, Luca Liberale, Fabrizio Montecucco. Precision medicine in intestinal ischemia: the emerging role of biomarkers. Internal and Emergency Medicine 2024; doi: 10.1007/s11739-024-03808-z
|
4 |
S. O’Neill, S. Yalamarthi. Systematic review of the management of ischaemic colitis. Colorectal Disease 2012; 14(11) doi: 10.1111/j.1463-1318.2012.03171.x
|
5 |
Ian Craig Lawrance. Biomarkers in Inflammatory Bowel Diseases. 2019; : 141 doi: 10.1007/978-3-030-11446-6_12
|
6 |
Priyanshee Gohil, Himani Thakkar, Unnati Gohil, Shrikalp Deshpande. Preliminary studies on the effect of rebamipide against the trypsin and egg-albumin induced experimental model of asthma. Acta Pharmaceutica 2011; 61(4): 427 doi: 10.2478/v10007-011-0033-3
|
7 |
A. I. Dolgushina, I. I. Shaposhnik, A. A. Seljanina, A. S. Kuznecova, V. V. Genkel. Chronic mesenteric ischemia: current state of the problem. Experimental and Clinical Gastroenterology 2020; (6): 166 doi: 10.31146/1682-8658-ecg-178-6-166-172
|
8 |
Antonella Maimone, Antonella De Ceglie, Peter D. Siersema, Todd H. Baron, Massimo Conio. Colon ischemia: A comprehensive review. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101592 doi: 10.1016/j.clinre.2020.101592
|
9 |
Yasuhito Funahashi, Masaki Yoshida, Tokunori Yamamoto, Tsuyoshi Majima, Shun Takai, Momokazu Gotoh. Intravesical Application of Rebamipide Promotes Urothelial Healing in a Rat Cystitis Model. Journal of Urology 2014; 192(6): 1864 doi: 10.1016/j.juro.2014.06.081
|
10 |
Yasuhito Funahashi, Masaki Yoshida, Tokunori Yamamoto, Tsuyoshi Majima, Shun Takai, Momokazu Gotoh. Intravesical Application of Rebamipide Suppresses Bladder Inflammation in a Rat Cystitis Model. Journal of Urology 2014; 191(4): 1147 doi: 10.1016/j.juro.2013.11.026
|
11 |
Kathy Navid, Umesh Gidwani, Juan Pena, Andrew Dunn. Ischemic Colitis. Hospital Medicine Clinics 2015; 4(2): 216 doi: 10.1016/j.ehmc.2014.12.002
|
12 |
Mikhail A. Osadchuk, Alexey M. Osadchuk. Erosive and ulcerative lesions of the digestive tract: optimization of diagnosis and management tactics. Terapevticheskii arkhiv 2022; 94(2): 271 doi: 10.26442/00403660.2022.02.201376
|
13 |
A. A. Frolova, T. S. Shindina, L. V. Maslovsky, M. L. Maksimov, E. B. Aleksandrova, O. E. Kropova. Gastroprotectant Rebamipide: review of action mechanisms and clinical applications. Glavvrač (Chief Medical Officer) 2022; (4): 11 doi: 10.33920/med-03-2204-02
|
14 |
Stephen O’Neill, Kenny Elder, Sarah J. Harrison, Satheesh Yalamarthi. Predictors of severity in ischaemic colitis. International Journal of Colorectal Disease 2012; 27(2): 187 doi: 10.1007/s00384-011-1301-x
|
15 |
Milica Markovic, Moran Zur, Arik Dahan, Sandra Cvijić. Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeability. European Journal of Pharmaceutical Sciences 2020; 152: 105440 doi: 10.1016/j.ejps.2020.105440
|